Bowman and Brooke Logo


While our firm is best known for defending automobile manufacturers, our lawyers counsel an array of Global 500 clients in high-stakes, national litigation in a range of industries.

Medical Device and Pharmaceutical

Stethoscope on a clipboard with medicine.

Bowman and Brooke’s medical device and pharmaceutical litigation practice group of experienced trial lawyers serves as national coordinating counsel, lead trial counsel – including at bellwethers – regional, and local counsel. With a passion and drive for mastering complex medical, scientific, epidemiological, engineering and regulatory issues, we represent manufacturers in widely publicized, highly complex cases, including mass torts, involving medical devices, prescriptions, over-the-counter medications, biologics and legacy drugs. Bowman and Brooke’s lawyers deliver legal representation that is innovative, cost effective and complementary to our clients’ core business objectives.

  • We understand our clients’ business needs and consistently deliver results that complement core business objectives with a proven approach that includes:
  • Developing a formidable defense strategy, rooted in science and aligned with business objectives
  • Coordinating a team of lawyers to implement a unified plan
  • Deploying the right lawyers to efficiently work up multiple cases simultaneously
  • Preparing discovery protocols and conducting large-scale document productions
  • Selecting, evaluating and preparing expert witnesses nationwide
  • Assessing litigation risks, and the regulatory impact of litigations and creating potential contingency plans
  • Ensuring a cutting-edge and consistent legal and appellate strategy
  • Trying cases to juries

Whether assessing product warnings and package inserts to meet FDA compliance, briefing and pleading appeals in federal and state courts, presenting before the JPML, arguing for early dismissals for lack of product identification, opposing class certification or heading to trial, Bowman and Brooke’s medical device and pharmaceutical team has the depth and experience necessary to critically evaluate claims and aggressively defend our Life Sciences clients.

  • Oct 04, 2016
    October 14, 2016, CA
    Firm Chair Paul Cereghini commented in Law360 following a class certification denial involving Breg, Inc.'s cold therapy devices. In Stacey Lucas et al. v. Breg Inc. et al., plaintiffs sought a nationwide class certification alleging that Breg, Inc. provided false and misleading instructions regarding the use of its Polar Care 500 device. 
  • Apr 21, 2016
    Orange County, CA
    During a trial in the Superior Court of California, County of Orange, a judge granted a motion of non-suit in favor of Breg, Inc. in a case involving a Breg Pain Care 3000 pain pump. William Stovall v. Breg, Inc., Superior Court of California, for the County of Orange – Civil Complex Center, Case No. 37-2011-00059728, Judge William Claster presiding.
  • Mar 15, 2015
    In McKenna v. Breg, Inc., a California appellate court upheld a jury verdict for device maker Breg, Inc. after a three and a half week trial in the Superior Court for the State of California for the first bellwether case in the California infusion pump JCCP to go to trial, a jury returned a complete defense verdict in favor of Breg, Inc.
  • Feb 06, 2013

    Breg, Inc. received a decisive win on February 6, 2013 in the first bellwether case in the California infusion pump JCCP to go to trial.

  • Jul 02, 2012
    After two days of deliberations in pain pump case, the judge ordered a mistrial.
  • October 12, 2022

    Austin Managing Partner Randy Christian, Minneapolis Executive Managing Partner Kim Schmid and Dallas Co-Managing Partner Alan Vickery have been named 2022 " Leading Life Sciences Lawyers" by LMG Life Sciences, a guide to leading firms and attorneys in life sciences.

  • August 31, 2022
    Legal Alert

    Bowman and Brooke LLP responds to high client demand by hiring six lawyers, including two first chair trial attorneys and four additional attorneys, as well as four legal professionals. The growth reflects the firm’s commitment to meeting the acute demands of a thriving national product liability defense practice while strengthening its litigation bench and trial capabilities within its Life Sciences practice group. 

  • June 10, 2022

    For the 15th year in a row, Bowman and Brooke has achieved national rankings by The Legal 500. The firm is named to all four Product Liability Defense categories—Automotive, Consumer, Pharmaceutical/Medical Device and Toxic Tort. Additionally, more than a dozen individual attorneys are recognized. 

  • May 2, 2022

    Bowman and Brooke LLP is proud to announce the additions of Partner Alan R. Vickery, Associate Sebastian Nuñez and the return of Senior Counsel Katherine M. Handy. These attorneys are dedicated to the defense of Global 500 manufacturers in product liability litigation, specifically for the firm’s automotive, consumer and life sciences clients. As a result of this and anticipated additional growth, the firm signed a new lease at Towne Square Place I in Plano, TX. 

  • December 7, 2022

    New Brunswick Managing Partner Chris Carton will be a panelist on the topic of “Lessons Learned from this Year’s Top MDLs: Key Defense Strategies from 3M Ear Plugs, Opioids and Zantac MDLs” at this year's annual ACI Drug and Medical Device Litigation Conference. 

Integrated Services

In addition to providing stellar legal counsel, we integrate our provision of other key services with the work of our legal teams. The result? Highly effective and efficient client service.